PET radiopharmaceuticals for imaging integrin expression: Tracers in clinical studies and recent developments

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Haubner, Roland ^a   Maschauer, Simone ^b   Prante, Olaf ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALFATIDE F 18; ALPHA FLUORO BETA ALANINE; ALPHAVBETA1 INTEGRIN; ALPHAVBETA6 INTEGRIN; ALUMINUM; FLUCICLATIDE F 18; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GLYCOPROTEIN; INTEGRIN; PENTAPEPTIDE; RADIOPHARMACEUTICAL AGENT; TRACER; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; BREAST CANCER; CLICK CHEMISTRY; CLINICAL TRIAL (TOPIC); DRUG HALF LIFE; DRUG LABELING; DRUG TARGETING; DRUG UPTAKE; HUMAN; LYMPH NODE METASTASIS; MELANOMA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; SOFT TISSUE SARCOMA; SQUAMOUS CELL CARCINOMA; CHEMISTRY; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; ISOLATION AND PURIFICATION; TISSUE DISTRIBUTION;

DIAGNOSTIC IMAGING; FLUORODEOXYGLUCOSE F18; HUMANS; INTEGRIN ALPHAVBETA3; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 84903625059     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/871609     Document Type: Article

References (87)

1. Margadant C., Monsuur H. N., Norman J. C., Sonnenberg A., Mechanisms of integrin activation and trafficking. Current Opinion in Cell Biology 2011 23 5 607 614 2-s2.0-80053321997 10.1016/j.ceb.2011.08.005
2. Welti J., Loges S., Dimmeler S., Carmeliet P., Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. The Journal of Clinical Investigation 2013 123 8 3190 3200 10.1172/JCI70212
3. Petrillo M., Scambia G., Ferrandina G., Novel targets for VEGF-independent anti-angiogenic drugs. Expert Opinion on Investigational Drugs 2012 21 4 451 472 2-s2.0-84858256127 10.1517/13543784.2012.661715
4. Seystahl K., Weller M., Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma? Expert Opinion on Investigational Drugs 2012 21 5 605 617 2-s2.0-84859708992 10.1517/13543784.2012.670219
5. Garmy-Susini B., Varner J. A., Roles of integrins in tumor angiogenesis and lymphangiogenesis. Lymphatic Research and Biology 2008 6 3-4 155 163 2-s2.0-58149087246 10.1089/lrb.2008.1011
6. Haubner R., Beer A. J., Wang H., Chen X., Positron emission tomography tracers for imaging angiogenesis. European Journal of Nuclear Medicine and Molecular Imaging 2010 37, supplement 1 S86 S103 2-s2.0-77956267966 10.1007/s00259-010-1503-4
7. Brooks P. C., Clark R. A., Cheresh D. A., Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994 264 5158 569 571 2-s2.0-0028362876
8. Gaertner F. C., Kessler H., Wester H. J., Schwaiger M., Beer A. J., Radiolabelled RGD peptides for imaging and therapy. European Journal of Nuclear Medicine and Molecular Imaging 2012 39, supplement 1 126 138
9. Mahabeleshwar G. H., Feng W., Phillips D. R., Byzova T. V., Integrin signaling is critical for pathological angiogenesis. The Journal of Experimental Medicine 2006 203 11 2495 2507 2-s2.0-33750499985 10.1084/jem.20060807 (Pubitemid 44664619)
10. Goh K. L., Yang J. T., Hynes R. O., Mesodermal defects and cranial neural crest apoptosis in α 5 integrin-null embryos. Development 1997 124 21 4309 4319 (Pubitemid 27496866)
11. 1 with the central cell-binding domain of fibronectin. The American Journal of Pathology 2000 156 4 1345 1362 2-s2.0-0033843942 (Pubitemid 30660012)
12. 1 expression and function during angiogenesis. The Journal of Biological Chemistry 2004 279 6 4862 4868 2-s2.0-1042301376 10.1074/jbc.M305190200 (Pubitemid 38199081)
13. 6 in cancer. Current Drug Targets 2009 10 7 645 652 2-s2.0-70249086983 10.2174/138945009788680374
14. 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. Journal of Cell Science 1995 108 6 2241 2251 2-s2.0-0028978232
15. 6 integrins. British Journal of Dermatology 1996 135 1 46 51 (Pubitemid 26225114)
16. 6 and the epithelial-mesenchymal transition (EMT). Cell Cycle 2005 4 10 1350 1352 2-s2.0-26444466006 (Pubitemid 41437119)
17. 18F]Galacto- RGD. PLoS Medicine 2005 2 3, article e70 2-s2.0-18244376347 10.1371/journal. pmed.0020070 (Pubitemid 40629471)
18. 18F-AH111585 in breast cancer patients. The Journal of Nuclear Medicine 2008 49 6 879 886 2-s2.0-44849137859 10.2967/jnumed.107.049452 (Pubitemid 351793427)
19. 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination. The Journal of Nuclear Medicine 2013 54 5 691 698 10.2967/jnumed.112.113563
20. 3 Nuclear Medicine and Biology 2013 40 1 33 41 10.1016/j.nucmedbio.2012.08.006
21. 19F- Arytrifluroborate in high yield and at extraordinarily high specific activity with preliminary in vivo tumor imaging. Nuclear Medicine and Biology 2013 40 6 841 849
22. 3 Angewandte Chemie 2013 52 44 11656 11659 10.1002/anie.201306376
23. 6 expression with positron emission tomography. Cancer Research 2007 67 16 7833 7840 2-s2.0-34548007871 10.1158/0008-5472.CAN-07-1026 (Pubitemid 47281378)
24. 6 The Journal of Nuclear Medicine 2013 54 7 1101 1105 10.2967/jnumed.112.110759
25. 3 integrin: design and applications of mono- and multifunctional RGD-based peptides and semipeptides. Current Medicinal Chemistry 2010 17 13 1255 1299 2-s2.0-77950674729 10.2174/092986710790936301
26. 3 expression. Journal of Labelled Compounds and Radiopharmaceuticals 2013 56 5 264 279 10.1002/jlcr.2999
27. 3-integrin expression in vivo. Accounts of Chemical Research 2009 42 7 969 980 2-s2.0-67651122837 10.1021/ar800243b
28. 18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. Bioconjugate Chemistry 2004 15 1 61 69 2-s2.0-0842263586 10.1021/bc034170n (Pubitemid 38165981)
29. 18F] fluoropropanethiol. Amino Acids 2009 37 4 717 724 2-s2.0-70349603826 10.1007/s00726-008-0200-0
30. 3 expression in vivo. Nuclear Medicine and Biology 2013 40 5 710 716 10.1016/j.nucmedbio.2013.04.003
31. 3 expression. Bioconjugate Chemistry 2007 18 6 1987 1994 2-s2.0-36849012163 10.1021/bc700226v (Pubitemid 350220000)
32. 18F-Glyco-RGD peptides for PET imaging of integrin expression: efficient radiosynthesis by click chemistry and modulation of biodistribution by glycosylation. Molecular Pharmaceutics 2014 11 2 505 515 10.1021/mp4004817
33. 18F-labeling of N-amino-oxy derivatized peptides. Bioconjugate Chemistry 2007 18 6 2085 2089 2-s2.0-36849050857 10.1021/bc700195y (Pubitemid 350220012)
34. 68Ga-labeled c(RGDyK)- isothiocyanatobenzyl-1,4,7-triazacyclononane-1, 4,7-triacetic acid and feasibility studies in mice. The Journal of Nuclear Medicine 2008 49 5 830 836 2-s2.0-44149120982 10.2967/jnumed.107.047423 (Pubitemid 351717550)
35. 3 integrin expression. European Journal of Nuclear Medicine and Molecular Imaging 2008 35 8 1507 1515 2-s2.0-48149103227 10.1007/s00259-008- 0757-6
36. 3 integrin expression. European Journal of Nuclear Medicine and Molecular Imaging 2011 38 7 1303 1312 2-s2.0-79958025504 10.1007/s00259-011- 1778-0
37. 68Ga-NOPO-c(RGDfK). Molecular Pharmaceutics 2014 11 5 1687 1695
38. 68Ga. Nuclear Medicine and Biology 2012 39 6 785 794 10.1016/j.nucmedbio.2012.01.003
39. 1? BioMed Research International. In press
40. 6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Research 2009 69 14 5843 5850 2-s2.0-67651006249 10.1158/0008-5472.CAN-08-4410
41. 18F]fluorine by copper-free, strain-promoted click chemistry. Nuclear Medicine and Biology 2013 40 2 233 239 10.1016/j.nucmedbio.2012.10.007
42. 6 The Journal of Pathology 2010 222 1 52 63 2-s2.0-77955490570 10.1002/path.2745
43. 6 Molecular Imaging and Biology 2014 10.1007/s11307-013-0717-9
44. 6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer. Clinical Cancer Research 2012 18 3 839 849 2-s2.0-84856513069 10.1158/1078-0432.CCR-11- 1116
45. 6 for tumor SPECT imaging. Molecular Pharmaceutics 2014 11 4 1208 1217 10.1021/mp400683q
46. 3 integrin antagonists: a new class of tracers for tumor targeting. The Journal of Nuclear Medicine 1999 40 6 1061 1071 2-s2.0-0032587186 (Pubitemid 29269229)
47. 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Research 2001 61 5 1781 1785 2-s2.0-0035266374 (Pubitemid 32691983)
48. 18F-Galacto-RGD in cancer patients. The Journal of Nuclear Medicine 2005 46 8 1333 1341 2-s2.0-25444503494 (Pubitemid 43733484)
49. 3 expression in man. Clinical Cancer Research 2006 12 13 3942 3949 2-s2.0-33746032220 10.1158/1078-0432.CCR- 06-0266 (Pubitemid 44078079)
50. 3 expression. The Journal of Nuclear Medicine 2006 47 5 763 769 2-s2.0-33745548133 (Pubitemid 46768438)
51. ICRP, Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007. Annals of the ICRP 2008 38 1-2 7 33 2-s2.0-62349083799 10.1016/j.icrp.2008.08.003
52. 3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck. Clinical Cancer Research 2007 13 22 6610 6616 2-s2.0-36749053493 10.1158/1078-0432.CCR-07-0528 (Pubitemid 350206795)
53. 18F] Galacto-RGD positron emission tomography. Neuro-Oncology 2009 11 6 861 870 2-s2.0-72449174017 10.1215/15228517-2009-024
54. 18F-galacto-RGD and 18F-FDG. The Journal of Nuclear Medicine 2008 49 1 22 29 2-s2.0-37649010525 10.2967/jnumed.107.045864
55. 3 integrin expression in normal and atherosclerotic artery. Circulation Research 1995 77 6 1129 1135 2-s2.0-0028829070
56. 3 integrin: potential role in human atherosclerosis. The American Journal of Pathology 2004 165 1 247 258 2-s2.0-3042690158 (Pubitemid 38821832)
57. 3 expression in human carotid atherosclerosis. JACC: Cardiovascular Imaging 2014 7 2 178 187
58. 18F-AH111585 in healthy volunteers. The Journal of Nuclear Medicine 2008 49 10 1664 1667 2-s2.0-53749107069 10.2967/jnumed.108.052126
59. 5-integrin imaging agent. The Journal of Nuclear Medicine 2011 52 3 424 430 2-s2.0-79952784609 10.2967/jnumed.110.077479
60. 3 integrin expression. Journal of Labelled Compounds and Radiopharmaceuticals 2009 52, supplement 1 S67 S73 10.1002/jlcr.1632
61. 3 expression in vivo. The Journal of Nuclear Medicine 2009 50, supplement 2 329
62. 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans. The Journal of Nuclear Medicine 2012 53 5 787 795 10.2967/jnumed.111.088955
63. 18F-FDG uptake pattern and microvessel density. The Journal of Nuclear Medicine 2009 50, supplement 2 1910
64. 68Ga-NOTA-RGD, a positron emission tomography agent for angiogenesis imaging. Cancer Biotherapy & Radiopharmaceuticals 2012 27 1 65 71 10.1089/cbr.2011.1061
65. Fanti S., Farsad M., Mansi L., PET-CT Beyond FDG: A Quick Guide to Image Interpretation 2010 Berlin, Germany Springer
66. 18F radiolabeling for PET. The Journal of Nuclear Medicine 2009 50 6 991 998 2-s2.0-66649112221 10.2967/jnumed.108.060418
67. 68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice. Bioconjugate Chemistry 2011 22 12 2415 2422 2-s2.0-84555177937 10.1021/bc200197h
68. Decristoforo C., Gallium-68-a new opportunity for PET available from a long shelflife generator automation and applications. Current Radiopharmaceuticals 2012 5 3 212 220 10.2174/1874471011205030212
69. Clarke E. T., Martell A. E., Stabilities of trivalent metal ion complexes of the tetraacetate derivatives of 12-, 13- and 14-membered tetraazamacrocycles. Inorganica Chimica Acta 1991 190 1 37 46 2-s2.0-44949272552
70. 3 integrin expression and facile radiosynthesis. The Journal of Nuclear Medicine 2011 52 8 1276 1284 2-s2.0-80051700245 10.2967/jnumed.111.087700
71. Mindt T. L., Struthers H., Brans L., Anguelov T., Schweinsberg C., Maes V., Tourwé D., Schibli R., "Click to chelate": synthesis and installation of metal chelates into biomolecules in a single step. Journal of the American Chemical Society 2006 128 47 15096 15097 2-s2.0-33845187817 10.1021/ja066779f (Pubitemid 44853517)
72. I-catalyzed alkyne-azide "click" cycloadditions from a mechanistic and synthetic perspective. European Journal of Organic Chemistry 2006 2006 1 51 68
73. 18F-labeling using click cycloadditions. BioMed Research International. In press
74. 18F-fluoroglycosylation: a short review. BioMed Research International. In press
75. 18F-labeling and glycosylation by click chemistry. Carbohydrate Research 2009 344 6 753 761 2-s2.0-63549126486 10.1016/j.carres.2009.02.001
76. 18F-glycopeptides as effective imaging probes for positron emission tomography. Angewandte Chemie 2010 49 5 976 979 2-s2.0-75749153010 10.1002/anie.200904137
77. 18F-AlF-NOTA-RGD2 for tumor angiogenesis PET imaging. European Journal of Nuclear Medicine and Molecular Imaging 2011 38 9 1732 1741 2-s2.0-80955178858 10.1007/s00259-011-1847-4
78. 18F labeling of peptides with a fluoride-aluminum- chelate complex. Bioconjugate Chemistry 2010 21 7 1331 1340 2-s2.0-77954881828 10.1021/bc100137x
79. 68Ga]Ga-NOTA-PRGD2 using a reference tissue model. PLoS ONE 2012 7 5 e37506 10.1371/journal.pone.0037506
80. 18F-labeled monomeric and dimeric RGD peptides using compartment model. Molecular Imaging and Biology 2012 14 6 743 752
81. 1 integrin receptor. ChemBioChem 2008 9 9 1397 1407 2-s2.0-49249138843 10.1002/cbic.200800045
82. 1 integrin from a phage display library. The Journal of Cell Biology 1994 124 3 373 380 2-s2.0-0027976103 (Pubitemid 24050355)
83. Logan D., Abu-Ghazaleh R., Blakemore W., Curry S., Jackson T., King A., Lea S., Lewis R., Newman J., Parry N., Rowlands D., Stuart D., Fry E., Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 1993 362 6420 566 568 2-s2.0-0027417816 10.1038/362566a0 (Pubitemid 23113036)
84. 6 is a receptor for foot-and-mouth disease virus. Journal of Virology 2000 74 11 4949 4956 2-s2.0-0033625053 10.1128/JVI.74.11.4949-4956.2000 (Pubitemid 30313833)
85. Burman A., Clark S., Abrescia N. G. A., Fry E. E., Stuart D. I., Jackson T., Specificity of the VP1 GH loop of foot-and-mouth disease virus for αv integrins. Journal of Virology 2006 80 19 9798 9810 2-s2.0-33748929004 10.1128/JVI.00577-06 (Pubitemid 44435654)
86. 6 integrin. The Journal of Biological Chemistry 1999 274 4 1979 1985 2-s2.0-0033593202 10.1074/jbc.274.4.1979 (Pubitemid 29061346)
87. 6 integrins for molecular stratification of idiopathic pulmonary fibrosis. The Journal of Nuclear Medicine 2013 54 12 2146 2152 10.2967/jnumed.113.120592